Trials / Recruiting
RecruitingNCT07197957
Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury
Clinical Utility of Cystatin C in the Early Detection of Contrast Induced Acute Kidney Injury
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- BayCare Health System · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine the clinical utility of serum cystatin C in early detection of acute kidney injury (AKI).
Detailed description
The primary objective of this study is to evaluate the clinical utility of Cystatin C in early detection of contrast-induced AKI. To evaluate the effect of patient characteristics in the Cystatin C based GFR estimation in comparison to Cr based estimation.
Conditions
Timeline
- Start date
- 2025-03-11
- Primary completion
- 2026-02-28
- Completion
- 2027-02-28
- First posted
- 2025-09-30
- Last updated
- 2025-09-30
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT07197957. Inclusion in this directory is not an endorsement.